Contributo di Maurizio De Luca 2022 AMERICAN SOCIETY FOR METBOLIC AND BARIATRIC SURGERY (ASMBS) AND INTERNATIONAL FEDERATION FOR THE SURGERY OF OBESITY AND METABOLIC DISORDERS (IFSO): INDICATIONS FOR METABOLIC AND BARIATRIC SURGERY.
Contributo: De Luca The Potential of Semaglutide Once-Weekly in Patients Without Type 2 Diabetes with Weight Regain or Insufficient Weight Loss after Bariatric Surgery - a Retrospective Analysis A Lautenbach, M Wernecke,
Contributo: Maurizio De Luca Association of Weight Loss Achieved Through Metabolic Surgery With Risk and Severity of COVID-19 Infection Ali Aminian, Chao Tu, Alex Milinovich, Kathy E. Wolski, Michael W. Kattan, Steven E. Nissen JAMA Surg. December 29, 2021.
Contributo: Maurizio De Luca METABOLIC SURGERY VERSUS CONVENTIONAL MEDICAL THERAPY IN PATIENTS WITH TYPE 2 DIABETES: 10-YEAR FOLLOW-UP OF AN OPEN-LABEL, SINGLE-CENTRE, RANDOMISED CONTROLLED TRIAL. G Mingrone, S Panunzi, A De Gaetano,
